If you’ve heard about Medicare’s new GLP-1 Bridge Program, you may be wondering: “Will Medicare pay for Wegovy® in 2026?” The short answer is yes—but it depends on why you’re taking Wegovy and whether you meet the program’s...
Why Are GLP-1 Medications Helping So Many Different Medical Conditions? For years, GLP-1 medications such as semaglutide (Wegovy®, Ozempic®) and tirzepatide (Zepbound®, Mounjaro®) were viewed primarily as weight-loss or diabetes medications. Today, researchers are...
The short answer is generally no. If you already receive coverage for a GLP-1 medication such as Ozempic® through your Medicare Part D prescription drug plan for Type 2 diabetes, you generally cannot switch to the Medicare GLP-1 Bridge Program. The Bridge Program was...
Published by DPC Medical-Dodson Pain Consultants, PA For millions of Americans, managing obesity and weight-related health conditions has been challenging—not only because of the complexity of weight loss itself, but also because of the cost of newer prescription...
For many people, losing weight isn’t simply a matter of eating less and exercising more. Obesity is now recognized as a chronic medical condition influenced by genetics, hormones, metabolism, medications, stress, sleep, and lifestyle. Fortunately, advances in...
